Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

Comprehensive biomarker testing can identify EGFR or other mutations in your lung cancer. Learn the benefits of testing and how it can help shape treatment.

Cockcroft–Gault, using TBW (mL/min) TBW(140 – age)/(72 x SCr) 75. . . Cockcroft–Gault, using IBW (mL/min) IBW(140 – age)/(72 x SCr) 50. . . Cockcroft–Gault ...

Each of your kidneys is made up of millions of nephrons (small units present inside the kidney ... Glomerular Filtrate Rate (GFR) is the best measure of kidney function. It tells how well ...

Improve workflow and productivity — when patients arrive for imaging sessions without a current creatinine/eGFR workup, the StatSensor Creatinine POC testing can avoid workflow interruptions and ...

Dave Fredrickson, head of AZ’s oncology business unit, said that the approval “reinforces Tagrisso as the backbone of EGFR-mutated lung cancer treatment,” adding that it is “especially ...

Tagrisso significantly improves overall survival in unresectable stage 3 EGFR-mutant NSCLC, surpassing placebo in the LAURA study. The FDA approved Tagrisso in September 2024 for patients with locally ...

Some non-small-cell lung cancers (NSCLC) have changes in a gene called EGFR. If your NSCLC has these mutations, your doctor likely will recommend treatment with targeted therapies that block EGFR.